Herbert Virgin's most recent trade in Vir Biotechnology Inc was a trade of 70,177 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on Aug. 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 09 Aug 2022 | 70,177 | 254,584 (0%) | 0% | 1.5 | 107,371 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 70,177 | 140,328 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 7,916 | 125,416 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.40 per share. | 09 Aug 2022 | 7,916 | 262,500 (0%) | 0% | 10.4 | 82,287 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 10 Mar 2022 | 9,000 | 184,407 (0%) | 0% | 1.5 | 13,770 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 9,000 | 210,505 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 70,000 | 175,407 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 1,375 | 219,505 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 22 Feb 2022 | 1,375 | 176,782 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Feb 2022 | 1,375 | 175,407 (0%) | 0% | 30 | 41,250 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 31.93 per share. | 17 Feb 2022 | 2,293 | 105,407 (0%) | 0% | 31.9 | 73,218 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 33.94 per share. | 08 Feb 2022 | 1,375 | 107,700 (0%) | 0% | 33.9 | 46,668 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 1,375 | 220,880 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 08 Feb 2022 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 25 Jan 2022 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 1,375 | 222,255 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 32.46 per share. | 25 Jan 2022 | 1,375 | 107,700 (0%) | 0% | 32.5 | 44,633 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 35.10 per share. | 11 Jan 2022 | 1,375 | 107,700 (0%) | 0% | 35.1 | 48,263 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 1,375 | 223,630 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 11 Jan 2022 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 39.95 per share. | 28 Dec 2021 | 1,375 | 107,700 (0%) | 0% | 39.9 | 54,931 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 1,375 | 225,005 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 28 Dec 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 14 Dec 2021 | 2,750 | 110,450 (0%) | 0% | 1.5 | 4,208 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,750 | 226,380 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 14 Dec 2021 | 2,750 | 107,700 (0%) | 0% | 50 | 137,500 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 1,375 | 229,130 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 45.88 per share. | 14 Dec 2021 | 1,375 | 107,700 (0%) | 0% | 45.9 | 63,085 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 14 Dec 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 30 Nov 2021 | 15,125 | 122,825 (0%) | 0% | 1.5 | 23,141 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 15,125 | 230,505 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 30 Nov 2021 | 13,750 | 107,700 (0%) | 0% | 50 | 687,500 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 45.60 per share. | 30 Nov 2021 | 1,375 | 121,450 (0%) | 0% | 45.6 | 62,700 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 32.67 per share. | 16 Nov 2021 | 1,375 | 107,700 (0%) | 0% | 32.7 | 44,921 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 1,375 | 245,630 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 16 Nov 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 36.94 per share. | 02 Nov 2021 | 1,375 | 107,700 (0%) | 0% | 36.9 | 50,793 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 1,375 | 247,005 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 02 Nov 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 38.87 per share. | 19 Oct 2021 | 1,375 | 107,700 (0%) | 0% | 38.9 | 53,446 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 19 Oct 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2021 | 1,375 | 248,380 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 33.75 per share. | 05 Oct 2021 | 1,375 | 107,700 (0%) | 0% | 33.7 | 46,406 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 1,375 | 249,755 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 05 Oct 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Sep 2021 | 8,000 | 251,130 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 22 Sep 2021 | 8,000 | 107,700 (0%) | 0% | 1.5 | 12,240 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 21 Sep 2021 | 4,125 | 99,700 (0%) | 0% | 50 | 206,250 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2021 | 4,125 | 259,130 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 21 Sep 2021 | 4,125 | 103,825 (0%) | 0% | 1.5 | 6,311 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 07 Sep 2021 | 4,125 | 103,825 (0%) | 0% | 1.5 | 6,311 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 4,125 | 263,255 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 07 Sep 2021 | 2,750 | 99,700 (0%) | 0% | 50 | 137,500 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 49.00 per share. | 07 Sep 2021 | 1,375 | 102,450 (0%) | 0% | 49 | 67,375 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 25 Aug 2021 | 2,750 | 99,700 (0%) | 0% | 50 | 137,500 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 25 Aug 2021 | 2,750 | 102,450 (0%) | 0% | 1.5 | 4,208 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2021 | 2,750 | 267,380 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 24 Aug 2021 | 1,375 | 99,700 (0%) | 0% | 48 | 66,000 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2021 | 1,375 | 270,130 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 24 Aug 2021 | 1,375 | 101,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 23 Aug 2021 | 13,750 | 99,700 (0%) | 0% | 50 | 687,500 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 13,750 | 271,505 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 23 Aug 2021 | 13,750 | 113,450 (0%) | 0% | 1.5 | 21,038 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 41.00 per share. | 10 Aug 2021 | 1,375 | 99,700 (0%) | 0% | 41 | 56,375 | Common Stock |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 1,375 | 285,255 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 10 Aug 2021 | 1,375 | 101,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |